Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRONTO II: Clevidipine in Acute Heart Failure
NCT04592380Phase 3Withdrawn
- Sponsor
- The Medicines Company
- Start
- Aug 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevidipine in Acute Heart Failure (AHF), hypertension (HTN), sponsored by The Medicines Company. Planned start Aug 2014; status: withdrawn.
02
Drugs
clevidipine
03
Conditions
Acute Heart Failure (AHF)hypertension (HTN)
Beyond the preview
Go deeper on NCT04592380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592380.